Stony Brook Surgery Research Team Awarded Grants for High-Tech Wound Care Solution
A research team led by Research Associate Professor of Surgery Gurtej Singh, from the Renaissance School of Medicine and Stony Brook Medicine’s Department of Surgery, has been awarded two grants totaling $696,431. These grants will build on previously awarded seed grants from the Department of Surgery and enable the team to continue research into tissue regeneration and the future of wound healing for patients with severe injuries.
The awards from The Mathers Foundation and the Technology Accelerator Fund are for $646,431 and $50,000, respectively. Singh’s team previously won the Long Island High Tech Incubator’s 2024 Venture Champions Challenge in the Life Sciences category for this high-tech wound-care solution and advanced healing patch. In addition, Singh had also received seed grants from the Stony Brook Department of Surgery in 2017 and 2019.
“The Department of Surgery has supported our early career research faculty through seed grants, and the grants awarded to Dr. Singh and his team are a testament of the importance of these investments,” said Department of Surgery Chair Apostolos Tassiopoulos, MD. “This support will empower the research team, led by Dr. Singh, to continue pursuing innovative ideas, enhance cross-departmental collaborations and translate research findings to the next generation of therapies. We are thrilled with the demonstrated confidence to our department and remain committed to pushing the boundaries of discovery and making meaningful scientific contributions.”
“The seed grants from the Department of Surgery were truly the initial catalysts for our research in tissue engineering and regenerative medicine,” said Singh. “They allowed us to purchase a 3D bioprinter and generate the first critical data on vascularized skin constructs. That early support made this line of research possible and directly contributed to the success of our Mathers Foundation grant.”
Among the next steps enabled by these grants, Singh and his team will use the funding to dissect the biological mechanisms of inosculation and optimize their vascularized scaffold design. And in a recent development, he shared that Stony Brook University’s Intellectual Property Partners recently filed a utility patent related to the team’s vascularized skin construct design — a major step toward commercialization.
“At Stony Brook Surgery, our culture of collaboration between clinical and basic sciences is driving transformative research,” added Singh.
Read the complete article on the Stony Brook Medicine Surgery blog.